OVERVIEW
Antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis (AAV) is a rare condition that affects several organ systems, has a high rate of mortality, and involves clinicians from several specialties. Current options for treatment are limited with significant safety issues and high relapse rate. It is important for clinicians to understand the therapeutic goals for treating AAV, including induction and maintenance of remission, as well as treatment of relapse. This live 60-minute interactive, CME-certified virtual symposium is an ACR Education Partner Program and will provide clinicians with expert insight on current standard of care, induction and maintenance of remission, and efficacy and safety data for emerging therapeutic approaches. As a bonus feature, attendees will have the opportunity to interact with faculty on a 1:1 basis to address case-based questions in virtual breakout rooms post-symposium.
Enhance Your Virtual Experience With Backstage Pass!
Join our 30-minute post-symposium conversation connecting the program speakers and audience in an intimate interactive session where you can address case-based questions, gain valuable insights, and facilitate relationship building. Participation with video encouraged.
GOAL STATEMENT
The goal of this activity is to develop activities to disseminate content from the ACR Convergence 2021 to healthcare providers who treat patients with rheumatic diseases.
LEARNING OBJECTIVES
Upon completion of this activity, participants will: Have increased knowledge regarding the[LIST][ITEM]Current standard of care for patients with AAV[ITEM]Clinical data of new and emerging therapies for AAV[/LIST]Have greater competence related to[LIST][ITEM]Selecting treatment to achieve remission in patients with AAV[/LIST]
ACCREDITATION STATEMENT
In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. [JALOGO] [MEDSCAPE]
[BOLD]For Physicians[/BOLD] Medscape, LLC designates this live activity for a maximum of 1.0 [italic]AMA PRA Category 1 Credits™[/italic]. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Supported by an independent educational grant by [bold]ChemoCentryx[/bold]
APPROVED ACR EDUCATION PARTNER: The activity is included in the ACR's Education Partner Program. Independent reporting and the viewpoints expressed are those of Medscape Education and its affiliates and do not represent the ACR.